FOLH1 and posterior cortical atrophy: Despite their high diagnostic performance for staging and re-staging of PCa, the urinary excretion of most PSMA radioligands presents a challenge, potentially limiting the localization of small lesions with subtle radiotracer avidity in the prostate bed as detection of recurrent disease on PET is adversely influenced by proximity to the bladder [11].